73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Novel combination of antibodies leads to significant improvement in cancer immunotherapy

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

byUniversity of BaselCredit: CC0 Public DomainThe simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demons
Quitting smoking tied to better survival in head, neck squamous cell carcinoma

Quitting smoking tied to better survival in head, neck squamous cell carcinoma

by Lori SolomonSmoking cessation for >10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study

Quitting smoking tied to better survival in head, neck squamous cell carcinoma

by Lori SolomonSmoking cessation for >10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study
New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t

New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by Delthia Ricks , Medical XpressAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainMedical investigators are theorizing that a combination of t
Integrating mental health services into oncology treatment protocols

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp
Collagen a key player in breast cancer metastasis

Collagen a key player in breast cancer metastasis

byGarvan Institute of Medical ResearchCollagen fibers running through a cancer tumor, created using a multiphoton microscope. The coloring is a visual representation of how collagen fibers are o

Collagen a key player in breast cancer metastasis

byGarvan Institute of Medical ResearchCollagen fibers running through a cancer tumor, created using a multiphoton microscope. The coloring is a visual representation of how collagen fibers are o
Chemotherapy drug temozolomide analog shows promise in treating glioma

Chemotherapy drug temozolomide analog shows promise in treating glioma

by Bob Yirka , Medical XpressCredit: Unsplash/CC0 Public DomainA team of researchers from Yale University and Yale School of Medicine has developed a temozolomide analog for use as a chemotherapy drug

Chemotherapy drug temozolomide analog shows promise in treating glioma

by Bob Yirka , Medical XpressCredit: Unsplash/CC0 Public DomainA team of researchers from Yale University and Yale School of Medicine has developed a temozolomide analog for use as a chemotherapy drug
Protein partnership effectively fends off pancreatic cancer progression

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1

Protein partnership effectively fends off pancreatic cancer progression

byVirginia Commonwealth UniversityModel for the functional interaction between Smad4 and Prdm16 during PDAC formation and progression. Credit:Journal of Cell Biology(2023). DOI: 10.1
New targets in the fight against pancreatic cancer

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e

New targets in the fight against pancreatic cancer

by Tokyo Medical and Dental UniversityTop, SETD1A, directly recruited to the RUVBL1 promoter, enhances RUVBL1 gene expression by increasing H3K4me3 levels in pancreatic cancer cells. Bottom, High co-e
Concerns around sex, fertility often ignored in breast cancer care: Survey

Concerns around sex, fertility often ignored in breast cancer care: Survey

by Cara MurezShehzin Tietjen was 27 years old when she felt a lump in one of her breasts while in the shower.That discovery led to a confirmation ofbreast cancer, an unexpected jolt at her age.

Concerns around sex, fertility often ignored in breast cancer care: Survey

by Cara MurezShehzin Tietjen was 27 years old when she felt a lump in one of her breasts while in the shower.That discovery led to a confirmation ofbreast cancer, an unexpected jolt at her age.
FDA Approves Lymphir: A New Hope for CTCL Patients

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.
CAR T cell therapy for T cell lymphoma shows promise in phase I trial

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou

CAR T cell therapy for T cell lymphoma shows promise in phase I trial

by Molly Chiu,Baylor College of MedicineCredit: Pixabay/CC0 Public DomainResearchers at the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital, and Hou
New experimental treatment can stop growth of schwannoma tumors

New experimental treatment can stop growth of schwannoma tumors

by Alan Williams,University of PlymouthCredit: Unsplash/CC0 Public DomainTwo novel and orally administered drugs can not only block the growth, but also shrink the size, of a tumor type found in

New experimental treatment can stop growth of schwannoma tumors

by Alan Williams,University of PlymouthCredit: Unsplash/CC0 Public DomainTwo novel and orally administered drugs can not only block the growth, but also shrink the size, of a tumor type found in